OBA One-Year Clinical Study Results Published in the Journal of Vascular Surgery

First, Large-Scale, Multicenter Clinical Trial Data Demonstrates Safety and Efficacy of the Tack Endovascular System®

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year results from its Tack Optimized Balloon Angioplasty (“TOBA”) clinical study were published in the July 2016 edition of the Journal of Vascular Surgery1.

The TOBA study enrolled 138 subjects at 13 sites in Europe. All study participants were suffering from peripheral artery disease caused by blockages in the superficial femoral or popliteal arteries, which are located in the upper part of the leg. All participants underwent percutaneous balloon angioplasty (“PTA”) with any dissections (or tears) resulting from PTA repaired using the Tack Endovascular System. The Tack® implant is a new technology designed to repair dissections in the artery wall that frequently occur as a complication during PTA. The system allows physicians to repair these dissections while leaving a minimal amount of foreign material in the artery, which reduces mechanical stress on the artery; leaves the artery in its most natural state; and preserves future treatment options. If the dissections are left unrepaired, they increase the probability of acute artery occlusion or may continue narrowing the artery.

Click here to read full press release.

©2020 PACT All Rights Reserved